"Obesity, in my point of view, should have been at the top of the list for employers as a cost driver years ago..." said Louise Short, MD, MSc, FACOEM from Brown & Brown Insurance. Check out this clip from our Vida Health webinar with Dr. Short. To view the full recording, check out the link in the comments.
Vida Health
Wellness and Fitness Services
San Francisco, California 35,305 followers
Diabetes and obesity outcomes. Guaranteed.
About us
At Vida, we help people get better — and we’re helping the healthcare system get better, too. Vida provides expert, personalized, on-demand health coaching and programs through a network of experienced health care providers — like dietitians, therapists, and health coaches — coupled with an easy-to-use app with award-winning content. We focus on chronic conditions — like diabetes, obesity, depression, and hypertension — which account for 80% of the $3 trillion spent on healthcare in the US. By combining advanced technology with top-notch healthcare providers, Vida is breaking down the barriers that have historically kept people from getting the best care. Vida’s cloud-based platform captures real-time data from 100 devices and apps and delivers AI-driven insights back to employers, health plans, and providers to improve care. We are trusted by Fortune 1000 companies, major national payers, and large providers to enable their employees to live their healthiest lives.
- Website
-
https://www.vida.com/
External link for Vida Health
- Industry
- Wellness and Fitness Services
- Company size
- 201-500 employees
- Headquarters
- San Francisco, California
- Type
- Privately Held
- Founded
- 2014
- Specialties
- Mobile Healthcare, Consumer and Enterprise Services, Chronic Condition Management, Digital Healthcare, Behavioral and Emotional Health, Health Coaching and Therapy, Digital Therapeutics, Mental Health, Diabetes Management, Whole Health, wellness, healthtech, and telehealth
Locations
-
Primary
San Francisco, California 94104, US
Employees at Vida Health
Updates
-
In addition to offering behavior change support and some basic prescribing for prediabetes, hypertension, diabetes, and its comorbidities, we offer medical weight loss for obesity and more intensive care for complex diabetes and comorbid obesity. Want to learn more? Check out our webpage dedicated to Vida Health's approach on treating obesity as a disease.
-
Join our next Vida Health webinar — Pioneering the Obesity Center of Excellence. We’ll be joined by #obesity expert Dr. Fatima Cody Stanford from Harvard Medical School on Monday, July 22 from 2-3 pm ET. Registration link in the comments.
-
-
GLP-1s have changed the game in cardiometabolic care, and they’re not going away any time soon. It’s important to get ahead of the cost trends by implementing the right utilization management strategy now. Don’t worry if that strategy evolves over time — in fact, it should. We’re here to help you through that evolution with a targeted approach to GLP-1 prescriptions along with additional tools like behavior change, medical nutrition therapy, alternative anti-obesity medications, mental health therapy, and more. When it comes to addressing GLP-1 demand in your population, we can either:
-
There's still time to register for our webinar tomorrow with Brown & Brown Insurance's Louise Short, MD, MSc, FACOEM. Join Louise, Gretchen Zimmermann, MBA, RD, CDCES, CSOWM, and Dominic Belmonte tomorrow at 3 pm ET / 12 pm PT as they discuss a clinical approach to evaluating #obesity solutions. Link to register in the comments.
-
-
In Pharmaceutical Strategies Group - PSG Trends in Drug Benefit Design Report, only 29% of respondents who reported their plan covers GLP-1s for obesity require participation in a lifestyle modification program and only 32% have implemented a step therapy approach. If cost containment is truly such a concern, why are these strategies being used by less than 1/3 of the respondents?
-
-
Don't forget to register to join us for a webinar on Wednesday, June 26, 3pm ET/12pm PT. Vida Health's VP of Clinical Strategy Gretchen Zimmermann, MBA, RD, CDCES, CSOWM, will be joined by the amazing Louise Short, MD, MSc, FACOEM, Brown & Brown Insurance's National Clinical Leader. They'll be discussing obesity solutions and how to evaluate them from a clinical perspective. Register here!
Join the webinar: A clinical approach to evaluating obesity solutions.
vida.zoom.us
-
Some really interesting findings in the latest Pharmaceutical Strategies Group - PSG Trends in Drug Benefit Design Report. It shows that employers and health plans have a similar approach to GLP-1 coverage for T2D (both above 90%) but varied with their #GLP1 coverage for #obesity — 37% of employers covering it vs. only 23% coverage from health plans. What do you think? Did you expect a higher percentage of coverage?
-